LPA and cancer: Aberrant LPA signaling has been linked to diverse conditions such as cancer [8,11]; besides, the high expression of the LPA1 receptor has been associated with malignant progression by enhancing proliferation, migration, angiogenesis and cancer stem-cell maintenance in several tumors such as breast cancer, pancreatic cancer, ovarian cancer and GBM [12,13,14,15].